0%
Daily Market Update
07-Mar-20251 min readvipin kumar

Trump delays Canada and Mexico tariffs for goods under USMCA – Daily Market Update 7th March 2025

Get a Smart Summary Instantly

Prompt copied

President Donald Trump exempted Mexican and Canadian goods covered by the North American trade agreement known as USMCA from his 25% tariffs, offering major reprieves to the US’s two largest trading partners.

Trump signed orders Thursday paring back the tariffs, which are related to illegal immigration and fentanyl tracking, until April 2. That is the date when the president is expected to start unveiling plans for so-called reciprocal duties on nations around the world as well as sector-specific duties.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled lower in range 1% to 2.5%.
  • European equity markets, barring FTSE, settled in green.
  • Asian equity markets are trading mix.
  • GIFT Nifty is little changed, Nifty futures likely to open around 22580 levels.

 

News highlights from across the globe

  • Stocks in the Asia-Pacific region are trading mix in early trade on Friday, tracking overnight losses on Wall Street as traders pull their money out of risky assets amid uncertainty over tariff.
  • Brent crude was trading 0.19% higher at $69.59 a barrel.

 

Important news updates from the domestic front

  • Kalpataru Projects International: KPIL bagged new orders worth Rs 2,306 crore for transmission and distribution business in overseas markets and building projects in India.
  • Jindal Stainless completed the sale of a 26% stake in Jindal Coke for Rs 195 crore.
  • NMDC, NMDC Steel: The government appointed Amitava Mukherjee as the chairperson and MD from March 6, 2025, till his superannuation on Feb. 29, 2028.
  • Eris Lifesciences is set to sell its complete stake in the two arms to unit Eris Therapeutics for the sum of Rs 862 crore.
  • Bharat Electronics secured additional orders worth Rs. 577 crore, bringing the total accumulated orders received by BEL during the current financial year to Rs.13,724 crore.
  • Bajaj Finserv’s unlisted insurance subsidiaries Bajaj Allianz General reported a gross direct premium at Rs 1,219 crore, while Bajaj Allianz Life Insurance Co. reported a total premium at Rs 1,080 crore.
  • Firstsource Solutions launched Agentic AI Studio which uses AI to break down work into specialized tasks. The platform aims to integrate AI into operations, to make it more accessible.
  • Biocon: Biocon Biologics Ltd. and Civica Inc reported forming a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States.
  • Tata Consultancy Services signed an expanded deal with Northern Trust, a global financial institution, to centralise and standardise its custody operations across 99 direct and global markets.
  • Power Grid Corp was declared as a successful bidder under tariff-based competitive bidding for three projects to establish the interstate transmission system under build, own, operate and transfer basis.
  • Laurus Labs approved an investment of Rs 83.3 crore in KRKA Pharma to acquire land and set up a manufacturing facility for new markets, including India.
  • Aarti Drugs received a SEBI warning letter in connection with an investigation into trading activities of certain entities.

 

Nifty Overview & Outlook

Benchmark Nifty index settled higher at 22544.70 levels after adding over 200 points to its previous closing values.

On the broader front, Smallcap index was up over 1%, on the other hand, Midcap cap index underperformed the benchmark and settled on a flat to positive note, up just 0.3%.

All sectoral indices, barring Realty, settled higher. Amongst them, Nifty Oil & Gas and Metal index were the top performers, rose 2.59% & 2.34% respectively.

Going ahead, we reiterate our view on Nifty index that sustenance above 22550 will be a positive development that might take it higher up to 22850 levels in immediate near term. On the down side, 22200 spot levels will act as immediate supports, positional supports are still placed around 21800-21680 levels.

 

Derivatives Overview & Outlook

Yesterday, Nifty futures added around 1.5% of open interest as long buildup whereas no significant change was seen in Banknifty, Finnifty and Midcapnifty futures on price as well as on open interest front.

All of F&O sectors, barring Telecom and Textile, settled on a positive note. Amongst them, Finance and Technology stocks witnessed maximum addition of long positions along with short covering in Capital Goods, Chemicals and Metal stocks.

On options front, Nifty will start the new weekly contract of March series with maximum positions at 23000 CE and 21500 PE.

 

Institutional Trading Activity

Yesterday, FIIs sold stocks worth Rs 2377 Cr in the cash segment, bought index futures worth Rs 1744 Cr also bought stock futures worth Rs 1677 Cr. DIIs were net buyers in the cash segment to the tune of Rs 1618 Cr

 

Nifty Futures, Banknifty Futures and Finnifty Key Levels

Nifty – Resistances 22700-22800; Supports 22520-22450

Banknifty – Resistances 48900-49100; Supports 48650-48500

Finnifty – Resistances 23300- 23380; Supports 23120-23080

 

F&O Security in Ban Today: MANAPPURAM

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.